{"id":66999,"date":"2025-04-24T12:01:48","date_gmt":"2025-04-24T12:01:48","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/04\/24\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/"},"modified":"2025-04-24T12:01:48","modified_gmt":"2025-04-24T12:01:48","slug":"cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/","title":{"rendered":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025"},"content":{"rendered":"<div>\n<p align=\"left\">SAN DIEGO, April  24, 2025  (GLOBE NEWSWIRE) &#8212; Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak<sup>\u00ae<\/sup> platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its first quarter 2025 financial results and operational highlights after the close of the U.S. financial markets on Thursday, May 8, 2025. The Company will host a conference call and webcast at 5:00 PM Eastern Time to discuss the results and provide an update on business operations.<\/p>\n<p><strong>Conference Call Dial-In &amp; Webcast Information<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:15%; width:15%; min-width:15%;;padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">Date:<\/td>\n<td style=\"max-width:85%; width:85%; min-width:85%;;padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">Thursday, May 8, 2025<\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">Time:<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">5:00 PM Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">United States:<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">1-800-717-1738<\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">International:<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">1-646-307-1865<\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">Conference ID:<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">90743<\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">Webcast:<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oJibZCiPRG1SXBjyuhoMy42S0ycIgunxm3quSqep8qnNNs1Xju7nhUhXrhZ5NDsgDdikizB8O2cz3t7E6Ak4rNEZanDbLIPVnbLf6UXjgajsjaJifiBd9162T_w2kcB9WVOmXHV5JWeNogqZjZ57dA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Link<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">\u00a0<\/td>\n<td style=\"padding-left: 0 ; text-align: left ;  vertical-align: middle; vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p><strong>About Cidara Therapeutics<\/strong><br \/>Cidara Therapeutics is using its proprietary Cloudbreak<sup>\u00ae<\/sup>\u00a0platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment (Fc). Cidara\u2019s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation. In June 2023, CD388 was granted Fast Track Designation by the U.S. Food and Drug Administration (FDA), and the Company announced completion of Phase 2b enrollment in December 2024. Additional DFCs have been developed for oncology and in July 2024 Cidara received IND clearance for CBO421 which is intended to target CD73 in solid tumors. Cidara is headquartered in San Diego, California. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JpJxpJbzsq53LpJg26299JCwdGtRHg66Q676UF5ghFVbAX0wS5aCHx3Ti0WfkeCMlJ7CZ5VAgIA-pzb-mu9o1w==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.cidara.com<\/u><\/a>.<\/p>\n<p><strong>INVESTOR CONTACT:<\/strong><br \/>Brian Ritchie<br \/>LifeSci Advisors<br \/>(212) 915-2578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RmkvNOnUAYaFJ6eJeSdRIOjFl80dFjBgBBRSDx8eQ6WAzLYbbdefLVWyrOWPyUjbVdiUxktIrh3Lo1-_b4J22jjClJkrATIDZY3E9Lg62lY46pjJAdqo7fNulFt8pert\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>britchie@lifesciadvisors.com<\/u><\/a><\/p>\n<p><strong>MEDIA CONTACT:<\/strong><br \/>Michael Fitzhugh<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DprULun6NM9_Hs3CRXSlI1dRkIh-R8MQ08-at9sRwsNTXZgQgt1FOspLxpS_3at4tHudoMgCNE3cSy-J40FUR5-oqc_FUcR0y4sbG8aL8zVtm_P8H-_-LhPGYB3msNay\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>mfitzhugh@lifescicomms.com<\/u><\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDViZmVhZGUtMDZhMC00MTgzLWJhNjItMjAwMTJjYWNiOWFjLTUwMDExMDg1NS0yMDI1LTA0LTI0LWVu\/tiny\/Cidara-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) &#8212; Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak\u00ae platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its first quarter 2025 financial results and operational highlights after the close of the U.S. financial markets on Thursday, May 8, 2025. [&#8230;]\n","protected":false},"author":1,"featured_media":67000,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025\" \/>\n<meta property=\"og:description\" content=\"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-24T12:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Cidara-Therapeutics-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025\",\"datePublished\":\"2025-04-24T12:01:48+00:00\",\"dateModified\":\"2025-04-24T12:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\",\"name\":\"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-04-24T12:01:48+00:00\",\"dateModified\":\"2025-04-24T12:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/","og_locale":"en_US","og_type":"article","og_title":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025","og_description":"SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) &#8212; Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak?","og_url":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-04-24T12:01:48+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Cidara-Therapeutics-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025","datePublished":"2025-04-24T12:01:48+00:00","dateModified":"2025-04-24T12:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/"},"wordCount":262,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/","url":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/","name":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-04-24T12:01:48+00:00","dateModified":"2025-04-24T12:01:48+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/cidara-therapeutics-to-report-first-quarter-2025-financial-results-and-host-inaugural-quarterly-conference-call-on-may-8-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=66999"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66999\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/67000"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=66999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=66999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=66999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}